SK Capital Announces Agreement to Acquire Perrigo Company plc’s Active Pharmaceutical Ingredients Business
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 9/22/2026
- S&P 500, Dow set for higher open with focus on Mideast developments
- AI and earnings keep driving markets as focus shifts to Trump-Xi summit
- Meta bull case increasingly playing out, Mizuho says
- Oil falls to two-week low as Gulf supply outlook improves
- Don’t expect a grand bargain from the Trump-Xi summit: Yardeni
- Pennsylvania measles cases near 800 as outbreak grows
- A timeline of Trump administration moves to weaken endangered species protections
- Meta AI agent ‘Muse’ triggers massive tech rally as chips and Wall Street soar
- Nasdaq notches record-high close, AI optimism reignites and Treasury yields retreat
- SpaceX and Tesla’s AI linkup is getting deeper. Here’s what Morgan Stanley sees
Perrigo Co. (PRGO) PT Raised to $71 at Jefferies; Reiterates Hold
August 11, 2017 8:17 AM EDTJefferies raised its price target on Perrigo Co. (NYSE: PRGO) to $71.00 (from $69.00) while maintaining a Hold rating. Jefferies increased FY17 revenues and EPS estimates by $84M and $0.25 to $4.80B and $.4.54 vs managements guidance of $4.70-4.85B and $4.45-4.70. Primarily reflecting encouraging signs of a... More
Perrigo Co. (PRGO) PT Raised to $93 at Cantor Fitzgerald
August 10, 2017 12:49 PM EDTCantor Fitzgerald analyst Louise Chen raised her price target on Perrigo Co. (NYSE: PRGO) to $93.00 (from $85.00) while maintaining an Overweight rating amid upwards earnings revisions and multiple expansion.
Chen commented, "Perrigo has been through a lot over the past two years,... More
